Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Por um escritor misterioso
Descrição
Full article: A novel class of broad-spectrum active-site-directed
The potency of halicin against the main protease of SARS-CoV-2
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19
Mechanism and inhibition of the papain‐like protease, PLpro, of
Conserved interactions required for inhibition of the main
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
Potent and selective covalent inhibition of the papain-like
Beyond the vaccines: a glance at the small molecule and peptide
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like
Targeting the Main Protease of SARS‐CoV‐2: From the Establishment
Development of highly potent non-covalent inhibitors of SARS-CoV-2
Drugs for Neglected Diseases initiative - DNDi on LinkedIn: Open
de
por adulto (o preço varia de acordo com o tamanho do grupo)
